Harvoni 61958-1805-01

Generic: Ledipasvir And Sofosbuvir

Package NDC

61958-1805-01

Product NDC: 61958-1805

Manufacturer: Gilead Sciences, Inc
Dosage Form: Pellet
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: August 28, 2019
Listing Expires: December 31, 2026
Application: NDA212477

Need to source Harvoni? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Ledipasvir	33.75 mg/1
Sofosbuvir	150 mg/1

Drug Class

Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]Hepatitis C Virus NS5A Inhibitor [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]

Selected Package

61958-1805-01Selected

90 PELLET in 1 PACKET (61958-1805-1)